MannKind | MNKD - Trade Creditors


MannKind reported $11.04M in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
Adma Biologics USD 31.72M 11.2M Jun/2026
BioCryst Pharmaceuticals USD 11.46M 501K Jun/2026
Eli Lilly USD 6.11B 1.08B Jun/2026
Halozyme Therapeutics USD 23.61M 9.51M Jun/2026
Insmed USD 74.55M 1.18M Jun/2026
Karyopharm Therapeutics USD 4.28M 276K Mar/2026
MacroGenics USD 3.44M 845K Jun/2026
MannKind USD 11.04M 5.1M Jun/2026
Merck USD 3.83B 36M Jun/2026
Minerva Neurosciences USD 640K 305K Dec/2025
Novavax USD 22.94M 6.84M Jun/2026
Novo Nordisk DKK 2.23B 131.82B Jun/2026
Pfizer USD 4.58B 75M Jun/2026
Sanofi EUR 23.6B 888M Jun/2026
Xencor USD 12.65M 4.73M Jun/2026